![](/img/cover-not-exists.png)
Safety, tolerability, and anti-tumor activity of olmutinib in non-small cell lung cancer with T790M mutation: A single arm, open label, phase 1/2 trial
Kim, Dong-Wan, Lee, Dae Ho, Han, Ji-Youn, Lee, Jongseok, Cho, Byoung Chul, Kang, Jin Hyoung, Lee, Ki Hyeong, Cho, Eun Kyung, Kim, Jin-Soo, Min, Young Joo, Cho, Jae Yong, An, Ho Jung, Kim, Hoon-Gu, LeeLanguage:
english
Journal:
Lung Cancer
DOI:
10.1016/j.lungcan.2019.07.007
Date:
July, 2019
File:
PDF, 555 KB
english, 2019